EUVIMEDEUVIMED entdecken
Kohortenstudie

Glucagon-Like Peptide-1 Receptor Agonists Added to Sodium-Glucose Cotransporter 2 Inhibitors in Type 2 Diabetes: A Historical Cohort Study Using the Diabetes Study From the Center of Tokyo Women's Medical University (DIACET)

Tetsuya Babazono, Hidekazu Murata, Manaka Sato, Masakazu Takeuchi

Tokyo Women's Medical University Journal · 2023-11 · 7 · 82-92

DOI: 10.24488/twmuj.2023005 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Tokyo Women's Medical University Journal, 2023-11. Verfasst von Tetsuya Babazono und 3 weiteren Autor:innen.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

This study clarifies the effects of adding a glucagon-like peptide-1 receptor agonist (GLP-1RA) to sodium-glucose cotransporter 2 inhibitor (SGLT2i) therapy on glycated hemoglobin (HbA1c) and body weight in Japanese patients with type 2 diabetes (T2D).

Methods

This historical cohort study, part of the Diabetes Study from the Center of Tokyo Women's Medical University, included 80 adults with T2D (registered April 2014-July 2020) prescribed SGLT2i for ≥3 months before adding GLP-1RA. HbA1c and weight changes to 12 months after GLP-1RA prescription were assessed, overall and in subgroups based on previous dipeptidyl peptidase-4 inhibitor use, body mass index (BMI), baseline HbA1c levels, and insulin use.

Results

HbA1c was significantly reduced from baseline (mean ± SD: 8.9 ± 1.6%) at all times, including 6 months (primary endpoint: 8.2 ± 1.3%; change: −0.76%, P = 0.002). At 12 months, 21.4% of individuals achieved HbA1c levels

Schlagwörter

combination therapyglucagon-like peptide-1 receptor agonistsodium-glucose transporter 2 inhibitortype 2 diabetes

Zitieren

APA

Babazono, T., Murata, H., Sato, M., & Takeuchi, M. (2023). Glucagon-Like Peptide-1 Receptor Agonists Added to Sodium-Glucose Cotransporter 2 Inhibitors in Type 2 Diabetes: A Historical Cohort Study Using the Diabetes Study From the Center of Tokyo Women's Medical University (DIACET). Tokyo Women's Medical University Journal, 7(0), 82-92. https://doi.org/10.24488/twmuj.2023005

Vancouver

Babazono T, Murata H, Sato M, Takeuchi M. Glucagon-Like Peptide-1 Receptor Agonists Added to Sodium-Glucose Cotransporter 2 Inhibitors in Type 2 Diabetes: A Historical Cohort Study Using the Diabetes Study From the Center of Tokyo Women's Medical University (DIACET). Tokyo Women's Medical University Journal. 2023;7(0):82-92. doi:10.24488/twmuj.2023005

BibTeX
@article{Babazono2023,
  author = {Babazono, Tetsuya and Murata, Hidekazu and Sato, Manaka and Takeuchi, Masakazu},
  title = {Glucagon-Like Peptide-1 Receptor Agonists Added to Sodium-Glucose Cotransporter 2 Inhibitors in Type 2 Diabetes: A Historical Cohort Study Using the Diabetes Study From the Center of Tokyo Women's Medical University (DIACET)},
  journal = {Tokyo Women's Medical University Journal},
  year = {2023},
  volume = {7},
  number = {0},
  pages = {82--92},
  doi = {10.24488/twmuj.2023005}
}
Kostenlos starten →